Thank you for donating!

You can donate using the following services.

Need support today?

Main menu

News

  1. 28.06.22

    Press Release: Xenpozyme® (olipudase alfa) approved by European Commission as first and only treatment for ASMD

    Read more

  2. 15.06.22

    IntraBio: IB1001-301 (UK Recruitment)

    Read more

  3. 30.05.22

    Mandos NPC1 Community Newsletter, May 2022

    Read more

  4. 24.05.22

    TransportNPC: Scott Fine, CEO of Cyclo Therapeutics

    Read more

  5. 20.05.22

    CHMP recommends approval of Xenpozyme® (olipudase alfa), the first and only treatment for ASMD

    Read more

2023 Niemann-Pick UK (NPUK). Registered Charity: England and Wales (1144406) / Scotland (SCO45407). Registered as a company limited by guarantee in England and Wales (07775835).

Donate today